|
Sign In to gain access to subscriptions and/or personal tools.
|
Periosteal Hyperostosis (Exostosis) in DBA/1 Male Mice
Joann C.L. Schuh
Immunex Corporation, 51 University Street, Seattle, Washington 98101, USA, schuhj{at}bainbridge.net
Randy Hall
Immunex Corporation, 51 University Street, Seattle, Washington 98101, USA
Dina Lambert
Immunex Corporation, 51 University Street, Seattle, Washington 98101, USA
Kim Harrington
Immunex Corporation, 51 University Street, Seattle, Washington 98101, USA
Ken Mohler
Immunex Corporation, 51 University Street, Seattle, Washington 98101, USA
Dauphine Barone
Immunex Corporation, 51 University Street, Seattle, Washington 98101, USA
Periosteal hyperostosis (exostosis) was identified in 5.9% (11/188) of DBA/1 male mice 10—14 weeks old used for collagen-induced arthritis (CIA) efficacy testing of immunomodulatory biologics. Mice with and without CIA in the affected limb, and also control and treated groups, were involved, with bilateral lesions in one mouse. Hyperostosis was characterized by circumferential and raised masses of variable location, length, and laterality, generally external to but occasionally breaching the periosteum of the metatarsals, metacarpals, tibia, femur, and humerus. Proportionally, the hyperostotic foci consisted of cancellous and woven bone, followed by osteoid, cartilage, and fibrous connective tissue and rarely infl ammatory cells. A displaced, presumably pathological fracture with callus formation was a concurrent lesion in only one case. Tartrate-resistant acid phosphatase-positive cells were frequent at bony interfaces, indicating an active resorptive process. Periosteal hyperostosi s is an incidental and potentially common finding in DBA/1 mice. Underreporting may occur due to the male bias in disease expression of this CIA model, sampling bias (generally paws only), tissue obliteration in the presence of CIA, and lack of comprehensive historical data on the background and aging lesions in this strain of mouse. Identification of such confounding bony lesions is important to the interpretation of efficacy studies, and suggests the need to further examine the biology of bone development in this strain of mouse.
Key Words: Animal model of human disease efficacy study murine collagen-induced arthritis musculoskeletal pathology.
References
- Campbell IK, Hamilton JA, Wicks IP (2000). Collagen-induced arthritis in C57BL/6 (H-2b) mice: New insights into an important disease model of rheumatoid arthritis. Eur J Immunol 30: 1568—1578.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Chhabra RS, Huff JE, Haseman J., Hall A., Baskin G., Cowan M. (1988). Inhibition of some spontaneou s tumors by 4-hexylresorcino l in F344/N rats and B6C3F1 mice. Fundam Appl Toxicol 11: 685—690.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Dougall WC, Glaccum M., Charrier K., Rohrback K., Brasel K., DeSmedt T., Daro E., Smith J., Tometsko ME, Maliszewski CR, Armstrong A., Shen V., Bain S., Cosman D., Anderson D., Morrissey PJ, Peschon JJ, Schuh JCL (2000). RANK is essential for osteoclast and lymph node development. Genes Dev 13: 2412—2424.[CrossRef][Web of Science]
- Durie FH, Fava R., Foy TM, Aruffo A., Ledbetter J., Aruffo A. (1993). Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science 261: 1328—1330.[Abstract/Free Full Text]
- Durie FH, Fava R., Noelle R. (1994). Collagen-induced arthritis as a model of rheumatoid arthritis. Clin Immunol Immunopathol 1: 11—18.[Medline]
[Order article via Infotrieve]
- Ferguson CM, Miclau T., Hu D., Alpern E., Helms JA (1998). Common molecular pathways in skeletal morphogenesi s and repair. Ann NY Acad Sci 857: 33—42.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Gustafsson K., Karlsson M., Andersson L., Holmdahl R. (1990). Structures on the I—A molecule predisposing for susceptibility to type II collagen-induce d autoimmune arthritis. Eur J Immunol 20: 2127 —2131.[Web of Science][Medline]
[Order article via Infotrieve]
- Holmdahl R., Andersson M., Goldsmidt TJ, Jansson L., Karlsson M., Malmstrom V., Mo J. (1989). Collagen-induced arthritis as an experimental model of rheumatoid arthritis. Immunogenetics, pathogenesis and autoimmunity. Acta Pathol Microbiol Immunol Scand (APMIS) 97: 575—584.[Web of Science][Medline]
[Order article via Infotrieve]
- Holmdahl R., Jansson L., Andersson M., Larsson E. (1988). Immunogenetics of type II collagen, autoimmunity and susceptibility to collagen arthritis. Immunology 65: 305—310.[Web of Science][Medline]
[Order article via Infotrieve]
- Johansson AC, Vestberg M., Holmdahl R. (2000). Non-major histocompatibility complex dependent variations in lymphocyte activity between inbred mouse strains susceptibleto various autoimmune diseases. Scand J Immunol 52: 21—29.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Karsenty G. (1998). Genetics of skeletogenesis. Dev Genet 22: 301—323.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Long PH, Leininger JR (1999). Bones, joints, and synovia. In: Pathology of the Mouse, Maronpot RR, Boorman GA, Gaul BW (eds). Cache River Press, Vienna, pp 645—678.
- Marusic A., Katavic V., Grcevic D., Lukic IK (1999). Genetic variability of new bone induction in mice. Bone 25: 25—32.[Medline]
[Order article via Infotrieve]
- Murray AB, Schmidt J., Rieke L. (1986). Retrovirus-induced osteopetrosis in mice. Am J Pathol 124: 319—323.[Abstract]
- Nii A., Reynolds DA, Young HA, Ward JM ( 1997). Osteochondrodysplasi a occurring in transgenic mice expressing interferon-
. Vet Pathol 34: 431— 441. - Okawa A., Goto S., Moriya H. (1999). Calcitonin simultaneously regulates both periosteal hyperostosi s and trabecular osteopeni a in the spinal hyperostotic mouse (twy/twy) in vivo. Calcif Tissue Int 64: 239—247.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Schmidt J., Casser-Bette M., Murray AB, Luz A., Erfle V (1987). Retrovirus-induced osteopetrosis in mice. Effects of viral infection on osteogenic differentiation in skeletoblast cell cultures. Am J Pathol 129: 503—510.[Abstract]
- Svensson L., Jirholt J., Holmdahl R., Jansson L. (1998). B cell-defi cient mice do not develop type II collagen-induced arthritis (CIA). Clin Exp Immunol 111: 521—526.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Watson WC, Townes AS (1985). Genetic susceptibility to murine collagen II autoimmune arthritis. Proposed relationship to the IgG2 autoantibody subclass response, complement C5, major histocompatibility complex (MHC) and non-MHC loci. J Exp Med 162: 1878—1891.[Abstract/Free Full Text]
- Wei X., Leung BP, Arthur HM, McInnes IB, Liew FY ( 2001). Reduced incidence and severity of collagen-induced arthritis in mice lacking IL-18. J Immunol 166: 517— 521.
- Yamasaki K., Itakura C. (1993). Osteosclerosis in aged ICR mice. Jpn J Vet Sci 47: 799—802.
Toxicologic Pathology, Vol. 30, No. 3,
390-393 (2002)
DOI: 10.1080/01926230252929963

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|